DavidAJacobsohnMDScM

PubMed

• A case report of myelodysplastic syndrome in a patient with PTPN11-related Noonan syndrome.
  JinJun Cheng, Christina Wiedl, Miriam Bornhorst, David Jacobsohn> ;Pediatric Blood & Cancer. 2024 Apr 11
• 11 citations
  Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.
  David Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney, Jörn C Albring, Mary Flowers, Alan P Skarbnik, Ibrahim Yakoub-Agha, Bor-Sheng Ko, Benedetto Bruno, Edmund K W...> ;Journal of Clinical Oncology. 2023 Apr 1
• 8 citations
  A diagnostic classifier for pediatric chronic graft-versus-host disease: results of the ABLE/PBMTC 1202 study.
  Geoffrey D E Cuvelier, Bernard Ng, Sayeh Abdossamadi, Eneida R Nemecek, Alexis Melton, Carrie L Kitko, Victor A Lewis, Tal Schechter, David A Jacobsohn, Andrew C Harri...> ;Blood Advances. 2023 Jul 25
• 14 citations
  Abatacept for GVHD prophylaxis can reduce racial disparities by abrogating the impact of mismatching in unrelated donor stem cell transplantation.
  Muna Qayed, Ben Watkins, Scott Gillespie, Brandi Bratrude, Kayla Betz, Sung Won Choi, Jeffrey H. Davis, Christine Duncan, Roger Giller, Michael Grimley, Andrew C. Harr...> ;Blood Advances. 2021 Nov 9
• 1 citations
  Antigen-specific T cell responses correlate with decreased occurrence of acute GVHD in a multicenter contemporary cohort.
  Conrad Russell Y. Cruz, Na Bo, Giorgos Bakoyannis, Kaylor E. Wright, Elizabeth Chorvinsky, Allison B. Powell, Catherine M. Bollard, David A. Jacobsohn, Kenneth R. Cook...> ;Bone Marrow Transplantation. 2021 Oct 28
• 5 citations
  Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults.
  Alexandra Dreyzin, David A. Jacobsohn, Anne L. Angiolillo, Birte Wistinghausen, Reuven J. Schore, Evelio Perez, Elizabeth Wells, Joshua Terao, Challice L. Bonifant, Ra...> ;Pediatric Hematology and Oncology. 2021 Oct 21
• 53 citations
  National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2020 Highly morbid forms report.
  Daniel Wolff, Vedran Radojcic, Robert Lafyatis, Resat Cinar, Rachel K. Rosenstein, Edward W. Cowen, Guang-Shing Cheng, Ajay Sheshadri, Anne Bergeron, Kirsten M. Willia...> ;Transplantation and Cellular Therapy. 2021 Oct 1
• 11 citations
  Metabolomic Identification of Alpha-Ketoglutaric Acid Elevation in Pediatric Chronic Graft-versus-Host Disease.
  Divya Subburaj, Bernard Ng, Amina Kariminia, Sayeh Abdossamadi, Madeline Lauener, Eneida R. Nemecek, Jacob Rozmus, Sandhya Kharbanda, Carrie L. Kitko, Victor Lewis, Ta...> ;Blood. 2021 Sep 17
• 8 citations
  Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival.
  Joseph Pidala, Lynn Onstad, Paul J. Martin, Betty K. Hamilton, Corey Cutler, Carrie L. Kitko, Paul A. Carpenter, George Chen, Mukta Arora, M.E. Flowers, Sally Arai, Am...> ;Blood Advances. 2021 Nov 23
• 5 citations
  Outcomes of pediatric patients with therapy-related myeloid neoplasms.
  Akshay Sharma, Sujuan Huang, Ying Li, Russell J. Brooke, Ibrahim Ahmed, Heather B. Allewelt, Persis Amrolia, Alice Bertaina, Neel S. Bhatt, Marc Bierings, Joshua J. Bi...> ;Bone Marrow Transplantation. 2021 Sep 3
• 59 citations
  Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transpla...
  Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori, Rebecca A. Marsh, Lauri Burroughs, Navneet S. Majhail, A. Samer Al-Homsi, Zaid ...> ;Transplantation and Cellular Therapy. 2021 Aug 1
• 4 citations
  Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-ri...
  Jenna Rossoff, David A. Jacobsohn, Morris Kletzel, Reggie E. Duerst, William T. Tse, Jennifer Schneiderman, Sonali Chaudhury> ;Pediatric Blood & Cancer. 2021 May 22
• 2 citations
  Impact of hospital acquired infections on post-transplant one year mortality in pediatric bone marrow transplant patients.
  Benjamin Hanisch, William Cohen, David A. Jacobsohn, Xiaoyan Song> ;American Journal of Infection Control. 2021 Feb 1
• 86 citations
  Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD.
  Kapoor, U., Kapoor, U., Kapoor, U., , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , > ;Journal of Clinical Oncology. 2021 Jan 15
• 2 citations
  Serious Adverse Events in Related Donors: A Report from the Related Donor Safe Study
  Matthew D. Seftel, Pintip Chitphakdithai, John P. Miller, Hati Kobusingye, Brent R. Logan, Michael L. Linenberger, Andrew S. Artz, Ann E. Haight, David A. Jacobsohn, M...> ;Transplantation and Cellular Therapy. 2021 Apr 1
• 31 citations
  Abatacept is effective as GVHD prophylaxis in unrelated donor stem cell transplantation for children with severe sickle cell disease
  Alexander Ngwube, Niketa Shah, Kamar Godder, David A. Jacobsohn, Monica L. Hulbert, Shalini Shenoy> ;Blood Advances. 2020 Aug 25
• 14 citations
  Assessment of ST2 for risk of death following graft-versus-host disease in pediatric and adult age groups.
  Courtney M. Rowan, Francis Pike, Kenneth R. Cooke, Robert A. Krance, Paul A. Carpenter, Christine Duncan, David A. Jacobsohn, Catherine M. Bollard, Conrad Russell Y. C...> ;Blood. 2020 Apr 23
• 41 citations
  Immune profile differences between chronic GVHD and late acute GVHD: results of the ABLE/PBMTC 1202 studies.
  Kirk R. Schultz, Amina Kariminia, Bernard Ng, Sayeh Abdossamadi, Madeline Lauener, Eneida R. Nemecek, Justin T. Wahlstrom, Carrie L. Kitko, Victor Lewis, Tal Schechter...> ;Blood. 2020 Apr 9
• 14 citations
  Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.
  Tal Schechter, Evelio Perez-Albuerne, Tiffany F. Lin, Meredith S. Irwin, Mohammed Sh. Essa, Ami V. Desai, Haydar Frangoul, Gregory A. Yanik, L. Lee Dupuis, David A. Ja...> ;Bone Marrow Transplantation. 2020 Mar 1
• 7 citations
  Driving the CAR to the Bone Marrow Transplant Program.
  Hema Dave, Lauren Jerkins, Patrick J. Hanley, Catherine M. Bollard, David A. Jacobsohn> ;Current Hematologic Malignancy Reports. 2019 Dec 1
• 27 citations
  Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients.
  Allistair Abraham, Tami John, Michael D. Keller, C. Russell N. Cruz, Baheyeldin Salem, Lauren Roesch, Hao Liu, Fahmida Hoq, Bambi Grilley, Adrian P. Gee, Hema Dave, Da...> ;Blood Advances. 2019 Jul 23
• 48 citations
  Benefits and challenges with diagnosing chronic and late acute GVHD in children using the NIH consensus criteria.
  Geoffrey D.E. Cuvelier, Eneida R. Nemecek, Justin T. Wahlstrom, Carrie L. Kitko, Victor Lewis, Tal Schechter, David A. Jacobsohn, Andrew C. Harris, Michael A. Pulsiphe...> ;Blood. 2019 Jul 18
• 10 citations
  Effect of Aging and Predonation Comorbidities on the Related Peripheral Blood Stem Cell Donor Experience: Report from the Related Donor Safety Study
  Michael A. Pulsipher, Brent R. Logan, Pintip Chitphakdithai, Deidre M. Kiefer, Marcie L. Riches, J. Douglas Rizzo, Paolo Anderlini, Susan F. Leitman, James W. Varni, H...> ;Biology of Blood and Marrow Transplantation. 2019 Apr 1
• 123 citations
  Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maravir...
  Javier Bolaños-Meade, Ran Reshef, Raphael Fraser, Mingwei Fei, Sunil Abhyankar, Zaid Al-Kadhimi, Amin M. Alousi, Joseph H. Antin, Sally Arai, Kate Bickett, Yi-Bin Chen...> ;The Lancet. Haematology. 2019 Mar 1
• 33 citations
  The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases
  Monica S. Thakar, Larisa Broglie, Brent R. Logan, Andrew S. Artz, Nancy Bunin, Lauri Burroughs, Caitrin Fretham, David A. Jacobsohn, Alison W. Loren, Joanne Kurtzberg,...> ;Blood. 2019 Feb 14
• Join now to see all

Journal Articles

• Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated Donors  
  Parameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
• Veno-Occlusive Disease After High-Dose Busulfan–Melphalan in Neuroblastoma  
  Gregory Yanik, Morris Kletzel, Stephan Grupp, David Jacobsohn, Christopher C Dvorak, Alix E Seif, Mark Ranalli, Haydar Frangoul, Nature

Abstracts/Posters

• Abatacept Is Effective for Gvhd Prophylaxis after Unrelated Donor Stem Cell Transplantation (URD SCT) for Severe Sickle Cell Disease (SCD)
  David Jacobsohn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Lectures

• Administration of Rimiducid Following Haploidentical BPX-501 Cells in Children with Malignant or Non-Malignant Disorders Who Develop Graft-Versus-Host-Disease (GvHD)Cl... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018